IGHE and cancer: Nevertheless, our findings in individuals with high total IgE (≥100 kU/L) may be consistent with a potential requirement for a critical threshold toward a classical IgE, rather than an alternative IgG4-biased TH2 immune response activation to confer for any potential protective benefits from cancer.